Tools & Calculators
Minimum Investment
TBA
TBA
TBA
TBA
TBA
NSE, BSE
TBA
TBA
TBA
TBA
TBA
TBA
TBA
TBA

Hexagon Nutrition Ltd. is a research-driven nutrition company specialising in the development and manufacturing of micronutrient premixes, branded wellness and clinical nutrition products, therapeutic formulations, and ready-to-use foods. The company operates three manufacturing units in India—at Nasik, Chennai, and Thoothukudi—and one international facility in Tashkent, Uzbekistan. Its product portfolio includes branded wellness and clinical nutrition (B2C), premix formulations (B2B2C), and ready-to-use foods under ESG initiatives. With a PAN-India omnichannel network and exports to over 75 countries, Hexagon Nutrition maintains a strong global presence.
Hexagon Nutrition Ltd. submitted its Draft Red Herring Prospectus (DRHP) to the Securities and Exchange Board of India (SEBI) on September 23, 2025, as part of its plan to raise capital through an Initial Public Offer (IPO). The proposed Hexagon Nutrition IPO will be a Book-Built Issue, comprising solely an Offer for Sale (OFS) of up to 3.09 crore equity shares. The company’s shares are proposed to be listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
While Kfin Technologies Ltd. has been appointed as the registrar for the issue, the book-running lead manager has not yet been announced. Essential details such as the IPO opening and closing dates, price band, and lot size are still awaited. As per the DRHP, the face value of each share is ₹1, and the total issue size stands at 3,08,59,704 shares, aggregating up to ₹[.] crore. Since this issue is an Offer for Sale, the company’s pre-issue and post-issue shareholding will remain unchanged at 11,06,27,404 shares. Investors can refer to the Hexagon Nutrition IPO DRHP for further information.
| Category | Details |
| Issue Type | Book Built Issue IPO |
| Total Issue Size | 3.09 crore equity shares |
| Fresh Issue | NA |
| Offer for Sale (OFS) | 3.09 crore equity shares |
| IPO Dates | TBA |
| Price Bands | TBA |
| Lot Size | TBA |
| Face Value | ₹10 per share |
| Listing Exchange | BSE, NSE |
| Shareholding pre-issue | 11,06,27,404 shares |
| Shareholding post-issue | 11,06,27,404 shares |
| Application | Lots | Shares | Amount |
| Retail (Min) | TBA | TBA | TBA |
| Retail (Max) | TBA | TBA | TBA |
| S-HNI (Min) | TBA | TBA | TBA |
| S-HNI (Max) | TBA | TBA | TBA |
| B-HNI (Min) | TBA | TBA | TBA |
| Investor Category | Shares Offered |
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
| KPI | Value |
| Earnings Per Share (EPS) | ₹0.51 |
| Price/Earnings (P/E) Ratio | TBD |
| Return on Net Worth (RoNW) | 12.46% |
| Net Asset Value (NAV) | ₹15.91 |
| Return on Equity (RoE) | 10.47% |
| Return on Capital Employed (RoCE) | 17.06% |
| EBITDA Margin | 12.33% |
| PAT Margin | 7.36% |
| Debt to Equity Ratio | 0.14 |
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 2,613.59 | 2,505.44 | 2,889.00 |
| Revenue | 3,249.29 | 2,977.31 | 2,785.01 |
| Profit After Tax | 243.77 | 122.14 | 58.24 |
| Reserves and Surplus | 1,831.18 | 1,648.10 | 1,520.21 |
| Total Borrowings | 266.00 | 368.93 | 518.73 |
| Total Liabilities | 671.78 | 746.71 | 1,258.16 |

Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
End-to-End Integrated Nutrition Player
Hexagon Nutrition is a fully integrated, holistic nutrition company, providing end-to-end solutions across the entire value chain. It is a market leader in customized micronutrient formulations and the only such holistic player in India offering products from premixes up to clinical and therapeutic nutrition, a capability that significantly distinguishes it within the industry.
Market Leadership in Premixes and MNPs
The company is recognized as one of India’s largest premix players, supplying customized vitamin and mineral premixes to leading domestic and multinational FMCG firms. Furthermore, it is one of the largest licensed suppliers of Micronutrient Powders (MNPs) under various UN programs, supporting global food fortification and critical public health initiatives.
Recognized Clinical and Wellness Brands
Hexagon has strategically moved up the value chain by developing successful in-house brands such as PENTASURE and OBESIGO. These brands cater to diverse and complex therapy areas, including renal, diabetes, and other specialized conditions. The company’s global footprint across over 70 countries reinforces its integrated and innovation-led position.
Strong Customer Relationships and Repeat Business
Hexagon boasts a track record of nurturing long-standing relationships across its B2C, B2B2C, and ESG segments, which drives high levels of repeat business. This continuity is a key indicator of customer satisfaction and product efficacy, providing the company with revenue predictability and a stable foundation for scalable growth.
Established In-House R&D Capabilities
The company maintains a competitive edge through its two dedicated in-house R&D facilities in Nasik and Chennai. This focus has yielded deep expertise in ingredient interaction and formulation science, ensuring premixes do not compromise the end product’s taste or quality, and maintaining an active new product innovation pipeline.
Scalable Manufacturing and Quality Assurance
Hexagon operates three manufacturing facilities in India and one in Uzbekistan, with the Indian sites strategically located in SEZ zones. Its infrastructure is designed for scale and efficiency, complemented by stringent quality and food safety standards evidenced by certifications like FSSC 22000 and GMP, reinforcing global product credibility.
Robust Omnichannel Distribution Network
The company ensures widespread accessibility through its pan-India omnichannel distribution. This includes retail pharmacies, hospital networks, leading e-commerce platforms, and its own brand websites. This, combined with a presence in over 20 countries for branded products, mitigates regional risk and leverages brand value.
Consistent Track Record of Financial Growth
Hexagon has demonstrated a consistent track record of growth in both revenues and profitability over the last three fiscals. This sustained financial performance, with an increase in Profit After Tax (PAT), reflects the scalability of its business model and its strong ability to generate long-term, sustained profitability.
Hexagon Nutrition Limited is a differentiated, research-oriented nutrition company offering a holistic range of products — from micronutrient premixes to therapeutic and clinical nutrition formulations. Recognised as one of India’s largest premix manufacturers, the company provides customised vitamin and mineral blends to leading Indian and multinational FMCG players. It is also among the top licensed suppliers of Micronutrient Powders (MNPs) under UN programmes, contributing significantly to food fortification and global health initiatives.
Journey and Growth
Founded in 1993 as a micronutrient formulation player, Hexagon Nutrition has steadily moved up the value chain. Over the years, it has developed successful brands such as Pentasure, Obesigo, and Pediagold, catering to adult, weight management, and paediatric nutrition respectively. In FY 2024, the company expanded its branded portfolio with Nutrone, strengthening its presence in the wellness and clinical nutrition market.
Integrated Operations and Global Presence
Hexagon Nutrition operates three manufacturing facilities in India—Nasik, Chennai, and Thoothukudi—and one in Tashkent, Uzbekistan. The SEZ-based plants in Chennai and Thoothukudi offer strategic advantages like duty-free imports and proximity to ports. Its products are exported to over 75 countries, supported by overseas offices in South Africa, Hong Kong, and Uzbekistan.
Product Segments
Commitment to Quality and Innovation
The company’s facilities are certified by FSSC 22000, GMP, and ISO 9001:2015, ensuring adherence to international standards. With a strong R&D team and a PAN-India omnichannel network, Hexagon Nutrition continues to drive innovation in nutrition science, enabling healthier lives worldwide.
Industry Outlook
The Indian nutrition industry — spanning dietary supplements, food fortification premixes, clinical nutrition, and therapeutic foods — is witnessing strong growth driven by rising health awareness, lifestyle shifts, and government-led nutrition initiatives.
Overall Nutrition & Supplement Market
Clinical & Therapeutic Nutrition Segment
Food Fortification & Micronutrient Premixes
Key Growth Drivers & Trends
| Name of the Company | Face Value (₹) | Revenue (₹ in Million) | Basic EPS (₹) | Diluted EPS (₹) | P/E | Return on Net Worth (%) | NAV (₹) |
| Hexagon Nutrition Limited | 1 | 13,249.29 | 1.75 | 1.75 | [●] | 12.46 | 15.91 |
| Peer Group | |||||||
| Zydus Wellness Limited | 2 | 27,089.00 | 10.90 | 10.90 | 45.64 | 6.12 | 178.26 |
| Nestlé India Limited | 10 | 202,015.60 | 16.63 | 16.63 | 71.44 | 77.91 | 121.35 |
Expand Product Portfolio into New Categories
Hexagon intends to achieve growth by expanding its product portfolio into new categories like functional foods, plant-based nutrition, and specialized maternal/geriatric products. This leverages its R&D and regulatory expertise to address evolving consumer health trends, diversify revenue streams, and strengthen its overall presence across both B2C and B2B2C segments.
Deepen Domestic Market Penetration
The company plans to significantly strengthen its footprint across India, where exports currently dominate revenue. It aims to leverage its international technical know-how to increase brand visibility and consumer awareness domestically. The strategy focuses on introducing new offerings in functional and therapeutic nutrition to broaden its Indian customer base.
Enhance Focus on Branded B2C Segment
Hexagon is committed to further emphasizing its branded nutrition segment (PENTASURE, OBESIGO, etc.) by augmenting online sales and expanding into Tier 2 and Tier 3 cities. It plans to double its sales field force within five years to increase reach and visibility, thereby strengthening market share in both existing and new geographies.
Capitalize on Post-COVID Nutritional Demand
The company is strategically responding to the increased global demand for immunity-building and fortified foods post-COVID-19. It aims to launch new products, such as fortified rice kernels (FRK), and expand its portfolio of clinically backed, fortified offerings to effectively participate in both public and private sector nutritional programs.
International Geographical Expansion
Hexagon continues to strengthen its global presence by strategically expanding its geographical footprint beyond existing markets. Utilizing regional hubs and a manufacturing facility in Uzbekistan, the company seeks to improve logistical efficiency and access to markets like CIS, Africa, and new high-growth regions such as Latin America and Eastern Europe.
Launch Products in New Therapy Areas and Formats
The company intends to broaden its offerings in clinical and wellness segments by entering new therapy areas (e.g., gynaecology, fertility, healthy ageing). It is also investing in innovative delivery formats like gummies, chewable tablets, and nutrition bars, which enhance consumer appeal and compliance, strengthening its competitive positioning.
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
You can apply via HDFCSky or other brokers using UPI-based ASBA (Application Supported by Blocked Amount).
Hexagon Nutrition Limited’s IPO is a Book Build Issue consisting entirely of an Offer for Sale of up to 3.09 crore shares.
The company filed its Draft Red Herring Prospectus (DRHP) with SEBI on September 23, 2025.
It is a research-driven nutrition company manufacturing micronutrient premixes, clinical nutrition, therapeutic foods, and wellness products.
The equity shares are proposed to be listed on both the NSE and BSE.
The price band, IPO opening and closing dates, and lot size are yet to be announced.